The Patent Finder

Insight Strategy & Marketing Ltd.

Also on record
Records under this name other than patents Insight Strategy & Marketing Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Insight Strategy & Marketing Ltd.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 6,190,875Method of screening for potential anti-metastatic and anti-inflammatory agents using mammalian heparanase as a probe
Formerly held
Term ended
Term ended Jul 10, 2018 · USPTO record
Term endedTerm ended Jul 10, 2018USPTO record
US 6,177,545Heparanase specific molecular probes and their use in research and medical applications
Formerly held
Term ended
Term ended May 1, 2018 · USPTO record
Term endedTerm ended May 1, 2018USPTO record
US 7,666,651Polypeptide having heparanase activity
Formerly held
Lapsed on the fee record
Ended Feb 23, 2018 · USPTO record
Lapsed on the fee recordEnded Feb 23, 2018USPTO record
US 6,348,344Genetically modified cells and methods for expressing recombinant heparanase and methods of purifying same
Formerly held
Term ended
Ended no later than Sep 2, 2017 · USPTO record
Term endedEnded no later than Sep 2, 2017USPTO record
US 6,426,209Genetically modified cells and methods for expressing recombinant heparanase and methods of purifying same
Formerly held
Term ended
Term ended Sep 2, 2017 · USPTO record
Term endedTerm ended Sep 2, 2017USPTO record
US 6,531,129Heparanase specific molecular probes and their use in research and medical applications
Formerly held
Term ended
Term ended Sep 2, 2017 · USPTO record
Term endedTerm ended Sep 2, 2017USPTO record
US 6,699,672Heparanase specific molecular probes and their use research and medical applications
Formerly held
Term ended
Ended no later than Sep 2, 2017 · USPTO record
Term endedEnded no later than Sep 2, 2017USPTO record
US 6,946,131Heparanase activity neutralizing anti-heparanase monoclonal antibody
Formerly held
Term ended
Ended no later than Sep 2, 2017 · USPTO record
Term endedEnded no later than Sep 2, 2017USPTO record
US 6,960,471Polynucleotide encoding a polypeptide having heparanase activity and expression of same in genetically modified cells
Formerly held
Term ended
Term ended Sep 2, 2017 · USPTO record
Term endedTerm ended Sep 2, 2017USPTO record
US 7,049,407Heparanase Specific Antibodies and Their Use in Research and Medical Applications
Formerly held
Term ended
Ended no later than Sep 2, 2017 · Low confidence
Term endedEnded no later than Sep 2, 2017Low confidence
10 of 22 patents shown.
Pro members see all 22.
Pro members: see all 22 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited